Peripheral Arterial Disease Trial, Recruiting NCT06067789 Sponsor: Ottawa Hospital Research Institute Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06067789
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who are scheduled for a planned leg artery surgery, either as a routine or urgent procedure — this includes certain types of bypass surgery or procedures to clear or repair a leg artery
  • People who have access to a telephone for follow-up calls after surgery

Who may not be able to join:

  • People for whom a spinal or epidural anaesthetic (a needle placed in the back to numb the lower body) is not safe — for example, due to blood clotting problems, an infection near the injection site, high pressure in the skull, low blood pressure, or a severe heart valve condition
  • People having surgery because of a traumatic injury to an artery (such as from an accident)
  • People with multiple sclerosis or other conditions that affect the protective coating around the nerves in the brain or spinal cord
  • People with a rare condition called malignant hyperthermia, or whose care requires avoiding certain anaesthetic triggers related to that condition
  • People who are pregnant
  • People who have already taken part in this study before, or who are currently in another research trial that could affect the results of this one (some exceptions may apply if the two study teams agree in writing)
  • People whose surgeon, anaesthetist, or other treating clinician determines that they would not be suitable for the study's random assignment process

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniel McIsaac, MD, The Ottawa Hospital

Phone: 613-798-5555

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ottawa Hospital Research Institute
Registry
ClinicalTrials.gov
Start date
25 March 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Monthly recruitment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov